Tumor Levels of the Mediators of ErbB2-driven Anoikis Resistance Correlate with Breast Cancer Relapse in Patients Receiving Trastuzumab-Based Therapies
Breast Cancer Research and Treatment(2021)
关键词
ErbB2/Her2,Trastuzumab,Irf6,EGFR,Neoadjuvant therapy,Immunohistochemistry
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要